Coverage access, affordability, and reforms to lower costs.
An article joins this feed when it matches these terms. Each one is also a search of its own.
Democrats look to build on the Inflation Reduction Act, and both parties seem to want to reform the pharmacy benefit manager industry; the US federal government and Gilead Sciences will go to trial this week in a multibillion-dollar dispute; the…
A divide between public and private health insurance leaves millions of patients facing unequal waiting times and financial incentives that shape medical care, intensifying a national debate over fairness and political reform. For Hontschik, the disparity is not merely a…
Investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to the White House last year, with his portfolio adding millions of dollars in stock in firms that benefited from a Republican-backed law that…
WASHINGTON — Investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to the White House last year, with his portfolio adding millions of dollars in stock in firms that benefited from a Republican-backed law…
A new report from congressional Democrats highlights ways the president has profited from regulatory changes for the pharmaceutical industry. According to the new report: Trump has made more stock trades since returning to office than everyone in Congress combined. The…
President Donald Trump signed “The One Big, Beautiful Bill Act” at the White House on July 4. Investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to the White House last year, with his…
The Nation New to The Nation? Subscribe Check out all installments in the OppArt series. Latest from the nation
Amye Joseph says America’s political polarization has made it an “interesting time” in her Tennessee household. She and her husband, Charlie, have been married 35 years. She’s a Republican. He’s a Democrat. But their shared disenchantment with profit-driven healthcare has provided…
Gov. Wes Moore offered his “public and loud” support for proposed legislation that would allow the state to more quickly reduce the price of some expensive drugs for non-Medicare recipients by piggybacking on the federally negotiated price limits under Medicare.
Home » International » Trump says chips, medicines coming back to US Posted By: Gopi October 14, 2026 Washington, Oct 15 (SocialNews.XYZ) US President Donald Trump has said the US would make half of the world’s semiconductors after Taiwan’s TSMC invested $265 billion in Arizona,…